Table 1.
Participant | Age (yr) | Gender | AIS | Level | Etiology | Time after injury (yr) | MAS score | Medication(s) |
---|---|---|---|---|---|---|---|---|
1 | 61 | M | D | C4 | T | 13.9 | 0 | None |
2 | 69 | M | D | T4 | NT | 7.0 | 0 | None |
3 | 66 | M | C | C5 | T | 17.0 | 0 | None |
4 | 58 | F | C | C4 | T | 6.0 | 0 | None |
5 | 69 | F | C | L3 | T | 2.5 | 0 | None |
6 | 28 | F | C | C5 | T | 2.2 | 0 | GBP |
7 | 70 | M | C | T11 | T | 3.4 | 1 | BAC |
8 | 68 | M | D | C3 | T | 11.0 | 1 | GBP, TIZ |
9 | 53 | M | D | L2 | T | 31.9 | 1 | BAC |
10 | 61 | M | D | C4 | NT | 4.1 | 1 | GBP |
11 | 41 | F | C | C1 | NT | 25.0 | 2 | BAC, GBP |
12 | 39 | M | C | C5 | T | 12.1 | 2 | None |
13 | 70 | M | C | C3 | T | 7.6 | 2 | BAC |
14 | 21 | F | C | C4 | T | 1.9 | 2 | None |
15 | 34 | M | D | C2 | T | 10.3 | 3 | None |
16 | 61 | M | C | T5 | NT | 41.0 | 3 | None |
17 | 37 | M | C | C5 | T | 2.2 | 3 | BAC |
18 | 42 | M | C | T2 | T | 2.1 | 3 | BAC |
19 | 67 | M | C | C7 | T | 3.0 | 3 | None |
20 | 41 | M | C | C5 | T | 16.0 | 3 | None |
21 | 44 | M | C | C4 | T | 10.3 | 3 | None |
22 | 71 | M | C | T7 | NT | 9.0 | 3 | None |
23 | 19 | F | C | T6 | T | 6.0 | 4 | BAC |
24 | 61 | M | D | C5 | T | 16.0 | 4 | None |
25 | 59 | M | C | C5 | T | 14.3 | 4 | BAC |
26 | 69 | M | D | C4 | T | 46.0 | 4 | BAC |
27 | 34 | M | C | T12 | T | 2.3 | 4 | BAC |
28 | 52 | M | C | T5 | T | 1.8 | 4 | BAC |
29 | 43 | M | C | C4 | T | 12.1 | 4 | BAC |
30 | 39 | M | C | T10 | T | 1.6 | 4 | BAC |
aT, traumatic; NT, non-traumatic; BAC, baclofen; GBP, gabapentin; TIZ, tizanidine.